124 filings
Page 2 of 7
F-1/A
wguog0tbwgjqf5
14 Dec 23
Registration statement (foreign) (amended)
5:20pm
CORRESP
q9fttdqz7l9d8glp
14 Dec 23
Correspondence with SEC
12:00am
6-K
5uava10
13 Dec 23
TC BioPharm Announces Plan to Implement ADS Ratio Change
9:05am
F-1/A
hrwsx urj54zi6i95z
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
424B3
9pf 90fgl7hv
8 Nov 23
Prospectus supplement
4:05pm
EFFECT
ux9jz7fjjdgn9 kpg
7 Nov 23
Notice of effectiveness
12:15am
F-3/A
yz1 qako8
2 Nov 23
Shelf registration (foreign) (amended)
1:11pm
6-K
vaoagcnzn3p xmyo14
2 Nov 23
Current report (foreign)
12:57pm
CORRESP
c8no6t28gi57 0iuebwy
2 Nov 23
Correspondence with SEC
12:00am
UPLOAD
l1hqsbl
4 Oct 23
Letter from SEC
12:00am
F-3
bwlykja
29 Sep 23
Shelf registration (foreign)
4:05pm
424B3
5czlkbef g4d8
1 Sep 23
Prospectus supplement
5:15pm
424B3
oyuf6 j2mzf6
1 Sep 23
Prospectus supplement
5:15pm
6-K
tpmi5lqlm9t7jfv
31 Aug 23
Current report (foreign)
8:00am
UPLOAD
lre0fqq
30 Aug 23
Letter from SEC
12:00am
F-1
2dnozh0bjlz8euyt31
28 Aug 23
Registration statement (foreign)
5:25pm
6-K
vchxxfg
22 Aug 23
Current report (foreign)
4:10pm
6-K
ozrs9fx wh14
31 Jul 23
Current report (foreign)
8:15am
6-K
owzej 5upld
24 Jul 23
Current report (foreign)
4:05pm
6-K
85rv1su6mp88ft m0fvw
10 Jul 23
Current report (foreign)
5:29pm